Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10426848
Humanized FcγR mice
granted -
US 10428008
Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions
granted -
US 10426810
Tangerine peel extract and its preparation and application
granted -
US 10428352
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10426766
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted -
US 10426746
Methods of treating developmental disorders with biguanides
granted -
US 10426712
Dental polymerizable composition
granted -
US 10426730
Oxidized cellulose microspheres
granted -
US 10426772
Use of ergot alkaloids as an anthelmintic agent
granted -
US 10426786
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
granted -
US 10426790
Treatment of allergic eye conditions with cyclodextrins
granted -
US 10426799
Methods for production of platelets from pluripotent stem cells and compositions thereof
granted -
US 10428314
Human ebola virus species and compositions and methods thereof
granted -
US 10426817
Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics
granted -
US 10426839
Pharmaceutical compositions comprising meloxicam
granted -
US 10426748
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 10426767
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10428200
Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups
granted -
US 10428157
Dosing regimens for use with PCSK9 inhibitors
granted -
US 10428143
Modulation of stimulatory and non-stimulatory myeloid cells
granted -
US 10428135
Fusion polypeptides capable of activating receptors
granted -
US 10428132
Tumor necrosis factor-related apoptosis-inducing ligand variant, as well as a preparation method and use thereof
granted -
US 10428126
Dermaseptin-type and piscidin-type antimicrobial peptides
granted -
US 10428113
Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.